Please use this identifier to cite or link to this item: https://ir.swu.ac.th/jspui/handle/123456789/17200
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAmornpetkul W.
dc.contributor.authorKanokrungsee S.
dc.contributor.authorKamanamool N.
dc.contributor.authorUdompataikul M.
dc.contributor.authorRojhirunsakool S.
dc.date.accessioned2022-03-10T13:16:37Z-
dc.date.available2022-03-10T13:16:37Z-
dc.date.issued2021
dc.identifier.issn14732130
dc.identifier.other2-s2.0-85101446138
dc.identifier.urihttps://ir.swu.ac.th/jspui/handle/123456789/17200-
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85101446138&doi=10.1111%2fjocd.13981&partnerID=40&md5=6a9a41cd87cad4c05933705ea590a082
dc.description.abstractBackground: Axillary hyperpigmentation (AH) is a condition in which axillary skin is darker than the adjacent areas. To date, there is no standard treatment for AH. The Q-switched neodymium-doped yttrium aluminum garnet 1064-nm(QS) laser and intense pulsed light (IPL) are two effective modalities for the treatment of pigmentary disorders; however, the efficacy and safety levels of both treatments for AH have not yet been compared in a controlled study. Aims: To evaluate and compare the efficacy and safety of the QS laser and IPL in the treatment of AH. Methods: A randomized, split-side study was conducted on 22 subjects; all subjects received a total of five split-side treatments every 2 weeks. The efficacy was determined using the melanin index (MI), color chart level using the Pantone SkinTone™ Guide, improvement grading scale (IGS), and patient satisfaction scores at weeks 2, 4, 6, 8, and 10. Results: The results showed that there was no significant difference in MI, color chart level, IGS, and patient satisfaction scores between the two treatments. Both treatments significantly improved AH after three sessions. However, the pain score was lower for IPL treatment. The adverse effects were transient and were found after IPL treatment in one participant (4.45%) who developed hyperpigmentation and another participant (4.45%) who developed erythema. Conclusions: Intense pulsed light therapy is safe and effective for the treatment of AH, with no significant difference in the outcome compared with QS laser treatment. © 2021 Wiley Periodicals LLC
dc.languageen
dc.subjectmelanin
dc.subjectadult
dc.subjectArticle
dc.subjectaxillary hyperpigmentation
dc.subjectclinical article
dc.subjectcomparative effectiveness
dc.subjectcontrolled study
dc.subjectdevice safety
dc.subjecterythema
dc.subjectfemale
dc.subjectfollow up
dc.subjecthuman
dc.subjecthyperpigmentation
dc.subjectintense pulsed light therapy
dc.subjectpain
dc.subjectpatient satisfaction
dc.subjectpostinflammatory hyperpigmentation
dc.subjectrandomized controlled trial
dc.subjectskin color
dc.subjecttreatment outcome
dc.subjectadverse device effect
dc.subjectadverse event
dc.subjecterythema
dc.subjecthyperpigmentation
dc.subjectskin
dc.subjectsolid state laser
dc.subjectErythema
dc.subjectHumans
dc.subjectHyperpigmentation
dc.subjectIntense Pulsed Light Therapy
dc.subjectLasers, Solid-State
dc.subjectSkin
dc.subjectTreatment Outcome
dc.titleComparison between the use of intense pulsed light and Q-switched neodymium-doped yttrium aluminum garnet laser for the treatment of axillary hyperpigmentation
dc.typeArticle
dc.rights.holderScopus
dc.identifier.bibliograpycitationJournal of Cosmetic Dermatology. Vol 20, No.9 (2021), p.2785-2793
dc.identifier.doi10.1111/jocd.13981
Appears in Collections:Scopus 1983-2021

Files in This Item:
There are no files associated with this item.


Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.